The North Carolina Biotechnology Center will host a workshop detailing the path to an IND. Attendees will include CEOs and executives from early-stage drug research and development companies seeking greater understanding of the IND process. Speakers will include representatives from clinical and contract research organizations and a variety of drug discovery companies. The workshop seeks to impart knowledge concerning the regulatory environment and process of IND submission to companies attempting to capitalize upon a new asset, as well as to offer service providers an opportunity to gain exposure to local drug development companies.